To stop ‘deserters’, reform tax system

New rules do nothing to deal with reasons why so many companies try to escape US taxes

M&A deal failure at highest since 2008

A total of $573bn worth of deals have been withdrawn so far

Mylan faces pressure over US executions

Generic drugmaker’s product set to be used for lethal injections

Nigeria uses Twitter for Ebola campaign

Vibrant social media spurs community initiative to combat virus

Small-cap Week, October 18

Connect Group, Scancell, Range Resources and Vertu Motors featured

Pfizer’s Astra pursuit suffers setback

Collapse of AbbVie’s bid for Shire diminishes chances of revised offer

week in review

Week in Review, October 18

UBS, EDF, Abbvie and Shire, and luxury groups featured

Regulator hits at ‘lottery’ of hospital safety

Standards in 4 out of 5 inspected inadequate or needing improvement

Interactive: Explore leading causes of death in developing countries

Examine our arrow diagram and heat map

An elderly man uses a magnifier to see the descriptions on a pack of medicine at a pharmacy in Dandong, Liaoning province March 30, 2011
©Jacky Chen/Reuter

Both medical systems and patients are crying out for care

Chances for investment exist but may not be so simple to grab

AbbVie drops proposed $54bn Shire deal

Drug groups’ tie-up is the biggest to be torpedoed by US crackdown on tax inversions

Tax changes roil inversion deals

Collapse of AbbVie-Shire does not herald the end

Roche sees sales of new cancer drugs rise

Swiss drugmaker expects single-digit sales growth

Ebola: how one company is trying to cope

Sierra Leone mining CEO faces challenges to keep staff virus free

In praise of tax inversions

Tax-driven deals are pallid and shaky

AbbVie drops £32bn bombshell on Shire

Panic set in as logic of takeover faced Treasury’s tax inversions crackdown

US tracks people on Ebola patient flight

Obama says US authorities know how to contain virus

China sends anti-Ebola drug to Africa

Military sends enough doses to treat 10,000 people

AbbVie reconsiders $54bn Shire deal

Tie-up could be biggest to be hit by US tax inversions crackdown

Eye disease trial raises stem cell hopes

Vision improved in macular degeneration patients

COMPANIES NEWS ON TWITTER

More FT Twitter accounts
SHARE THIS QUOTE